Ian D. Dang

Array ( [id] => 5473033 [patent_doc_number] => 20090246199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'THERAPEUTIC METHODS FOR INHIBITING TUMOR GROWTH WITH DLL4 ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/435030 [patent_app_country] => US [patent_app_date] => 2009-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10176 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246199.pdf [firstpage_image] =>[orig_patent_app_number] => 12435030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4451377 [patent_doc_number] => 07964701 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-21 [patent_title] => 'Alpha-fetoprotein peptides' [patent_app_type] => utility [patent_app_number] => 12/410612 [patent_app_country] => US [patent_app_date] => 2009-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8395 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/964/07964701.pdf [firstpage_image] =>[orig_patent_app_number] => 12410612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5929816 [patent_doc_number] => 20110039775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'THYROID STIMULATING HORMONE FUSION PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/933386 [patent_app_country] => US [patent_app_date] => 2009-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 65 [patent_figures_cnt] => 65 [patent_no_of_words] => 10463 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12933386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7811331 [patent_doc_number] => 08133862 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-13 [patent_title] => 'Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency' [patent_app_type] => utility [patent_app_number] => 12/405022 [patent_app_country] => US [patent_app_date] => 2009-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21615 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/133/08133862.pdf [firstpage_image] =>[orig_patent_app_number] => 12405022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5473610 [patent_doc_number] => 20090246776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'Modulators of scarb-1 for treating acne or hyperseborrhea' [patent_app_type] => utility [patent_app_number] => 12/320166 [patent_app_country] => US [patent_app_date] => 2009-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5122 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246776.pdf [firstpage_image] =>[orig_patent_app_number] => 12320166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7751217 [patent_doc_number] => 08110368 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-02-07 [patent_title] => 'Synuclein gamma as a biomarker of obesity and obesity-related disorders' [patent_app_type] => utility [patent_app_number] => 12/350213 [patent_app_country] => US [patent_app_date] => 2009-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 5765 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/110/08110368.pdf [firstpage_image] =>[orig_patent_app_number] => 12350213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5563657 [patent_doc_number] => 20090136509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Use of Toll-Like Receptor 4 Antagonists for the Treatment or Prevention of Osteoarthritic Conditions' [patent_app_type] => utility [patent_app_number] => 12/262699 [patent_app_country] => US [patent_app_date] => 2008-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 7586 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136509.pdf [firstpage_image] =>[orig_patent_app_number] => 12262699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4619213 [patent_doc_number] => 07998932 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'Inhibition of angiogenesis by neutrophil alpha-defensins' [patent_app_type] => utility [patent_app_number] => 12/247859 [patent_app_country] => US [patent_app_date] => 2008-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 16276 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/998/07998932.pdf [firstpage_image] =>[orig_patent_app_number] => 12247859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6125281 [patent_doc_number] => 20110086003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'STABILIZATION OF HYDROPHOBIC PROTEIN THERAPEUTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 12/738818 [patent_app_country] => US [patent_app_date] => 2008-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2150 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086003.pdf [firstpage_image] =>[orig_patent_app_number] => 12738818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585008 [patent_doc_number] => 20090104210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Peptide compounds for treating obesity and insulin resistance' [patent_app_type] => utility [patent_app_number] => 12/287211 [patent_app_country] => US [patent_app_date] => 2008-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17724 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20090104210.pdf [firstpage_image] =>[orig_patent_app_number] => 12287211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6476992 [patent_doc_number] => 20100285027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'ANTIBODIES SPECIFIC FOR HUMAN HEPCIDIN' [patent_app_type] => utility [patent_app_number] => 12/680977 [patent_app_country] => US [patent_app_date] => 2008-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5402 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285027.pdf [firstpage_image] =>[orig_patent_app_number] => 12680977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6504370 [patent_doc_number] => 20100260772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'METHODS FOR TREATING OR PREVENTING DISEASES ASSOCIATED WITH LOW BONE MASS' [patent_app_type] => utility [patent_app_number] => 12/680391 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 6104 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20100260772.pdf [firstpage_image] =>[orig_patent_app_number] => 12680391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9239184 [patent_doc_number] => 08603973 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Skincare composition comprising HSA fusion protein, preparation method and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/529981 [patent_app_country] => US [patent_app_date] => 2008-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 8268 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12529981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6534722 [patent_doc_number] => 20100204107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'USE OF URODILATIN AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677105 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34871 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204107.pdf [firstpage_image] =>[orig_patent_app_number] => 12677105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6596489 [patent_doc_number] => 20100292132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'USE OF INSULIN C-PEPTIDE, ALONE OR IN COMBINATION WITH GLP-1, AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/676899 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39435 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292132.pdf [firstpage_image] =>[orig_patent_app_number] => 12676899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6054589 [patent_doc_number] => 20110110949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'NESFATIN-1 SPECIFIC ANTIBODY AND THE USE THEREOF, AND NESFATIN SPECIFIC ANTIBODY AND THE USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/674902 [patent_app_country] => US [patent_app_date] => 2008-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 24519 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110949.pdf [firstpage_image] =>[orig_patent_app_number] => 12674902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4494806 [patent_doc_number] => 07947449 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-24 [patent_title] => 'Methods of diagnosing pre-eclampsia or eclampsia' [patent_app_type] => utility [patent_app_number] => 12/221623 [patent_app_country] => US [patent_app_date] => 2008-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 15 [patent_no_of_words] => 26851 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/947/07947449.pdf [firstpage_image] =>[orig_patent_app_number] => 12221623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8027475 [patent_doc_number] => 08142817 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-27 [patent_title] => 'Composition for restoration of age related tissue loss in the face or selected areas of the body' [patent_app_type] => utility [patent_app_number] => 12/218334 [patent_app_country] => US [patent_app_date] => 2008-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5167 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/142/08142817.pdf [firstpage_image] =>[orig_patent_app_number] => 12218334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6395703 [patent_doc_number] => 20100178320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-15 [patent_title] => 'NEW MEDICAL PRODUCTS' [patent_app_type] => utility [patent_app_number] => 12/666116 [patent_app_country] => US [patent_app_date] => 2008-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11527 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20100178320.pdf [firstpage_image] =>[orig_patent_app_number] => 12666116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228848 [patent_doc_number] => 20100183586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'METHOD FOR DETECTION OR TREATMENT OF GRAFT VERSUS HOST DISEASE' [patent_app_type] => utility [patent_app_number] => 12/666209 [patent_app_country] => US [patent_app_date] => 2008-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 8578 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183586.pdf [firstpage_image] =>[orig_patent_app_number] => 12666209 [rel_patent_id] =>[rel_patent_doc_number] =>)